تقرير
Early Achromobacter xylosoxidans Endocarditis After the Valvular Mitral Replacement Complicated by an Agranulocytosis on B-lactams: A Case Report.
العنوان: | Early Achromobacter xylosoxidans Endocarditis After the Valvular Mitral Replacement Complicated by an Agranulocytosis on B-lactams: A Case Report. |
---|---|
المؤلفون: | Channaoui A; Cardiac Surgery Department, Centre Hospitalier Régional Sambre et Meuse, Namur, BEL., Dubus M; Cardiac Surgery Department, Centre Hospitalier Régional Sambre et Meuse, Namur, BEL., Mathieu F; Cardiology Department, Centre Hospitalier Régional Sambre et Meuse, Namur, BEL., Noirhomme S; Infectious Disease Department, Centre Hospitalier Régional Sambre et Meuse, Namur, BEL., Fontaine R; Cardiac Surgery Department, Centre Hospitalier Régional Sambre et Meuse, Namur, BEL. |
المصدر: | Cureus [Cureus] 2023 Sep 27; Vol. 15 (9), pp. e46045. Date of Electronic Publication: 2023 Sep 27 (Print Publication: 2023). |
نوع المنشور: | Case Reports |
اللغة: | English |
بيانات الدورية: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Palo Alto, CA : Cureus, Inc. |
مستخلص: | An immunocompetent 82-year-old woman developed endocarditis caused by an atypical organism called Achromobacter xylosoxidans, after a first valvular surgery. The intravenous antibiotic therapy with ceftazidime - 2 g every 8 hours during five weeks - a key part of the treatment, induced agranulocytosis as an adverse event. Cross-reactivity between antibiotics was suspected. Finally, the patient's cure was the result of a coordinated effort between medical and surgical professionals. Postoperative follow-up is six years. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Channaoui et al.) |
References: | Eur J Clin Microbiol Infect Dis. 2007 Jun;26(6):435-7. (PMID: 17516103) Am J Case Rep. 2020 Jul 21;21:e923031. (PMID: 32747617) G Ital Cardiol (Rome). 2016 Apr;17(4):277-319. (PMID: 27093212) West J Med. 1982 Feb;136(2):153-7. (PMID: 7064475) Clin Infect Dis. 2000 Apr;30(4):633-8. (PMID: 10770721) J Med Microbiol. 2008 Apr;57(Pt 4):525-527. (PMID: 18349376) J Thorac Cardiovasc Surg. 2019 Feb;157(2):555-566. (PMID: 30385026) Can J Infect Dis Med Microbiol. 2011 Fall;22(3):e17-20. (PMID: 22942890) Lancet. 2016 Feb 27;387(10021):882-93. (PMID: 26341945) Autops Case Rep. 2017 Sep 30;7(3):50-55. (PMID: 29043211) Eur J Cardiothorac Surg. 2017 Oct 1;52(4):768-774. (PMID: 28575189) Eur Heart J. 2023 Oct 14;44(39):3948-4042. (PMID: 37622656) Intern Med. 2012;51(9):1133-8. (PMID: 22576403) |
فهرسة مساهمة: | Keywords: achromobacter xylosoxidans; adverse drug event; agranulocytosis; mitral endocarditis; mitral valve surgery |
تواريخ الأحداث: | Date Created: 20231030 Latest Revision: 20231031 |
رمز التحديث: | 20231031 |
مُعرف محوري في PubMed: | PMC10603368 |
DOI: | 10.7759/cureus.46045 |
PMID: | 37900458 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2168-8184 |
---|---|
DOI: | 10.7759/cureus.46045 |